Pharma Journalist -

Vertex Pharmaceuticals Incorporated announced that the company has entered into a definitive agreement under which Vertex will acquire ViaCyte, a privately held biotechnology company…
Read More...

WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) dedicated to end-to-end bioconjugates services, and AbTis, a Korean biotechnology…
Read More...

ADC Therapeutics SA announced it has entered into an exclusive license agreement with Swedish Orphan Biovitrum AB (Sobi) for the development and commercialization of ZYNLONTA for all…
Read More...

Pfizer Inc. and BioNTech SE announced the U.S. Food and Drug Administration (FDA) approved the companies’ supplemental Biologics License Application (sBLA) for their COVID-19 vaccine,…
Read More...

Horizon Therapeutics plc announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) expanding the labeling to include…
Read More...

SAE Media Group reports: the Oligonucleotide Therapeutics Conference will touch on the Draft Guidance on CMC for Individualized ASO Therapies SAE Media Group proudly presents the…
Read More...

SAE Media Group reports: The full agenda and speaker line-up are now available to download for the 3rd Annual Wearable Injectors and Connected Devices Conference, returning in October…
Read More...

Exelixis, Inc. and Ryvu Therapeutics S.A. announced that the companies have entered into an exclusive license agreement focused on the development of novel targeted therapies utilizing…
Read More...

BeiGene announced it entered into a worldwide strategic collaboration with InnoRNA, a biotechnology company with expertise in LNP-based delivery technology and mRNA drug discovery, to…
Read More...

Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, and TSB…
Read More...